Literature DB >> 15491299

Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T-->C promoter mutation in non-erythroid tissues.

Asok Chaudhuri1, Genevieve Yuen, Flora Fang, Jill Storry.   

Abstract

Blood group Duffy gene (FY) promoter in Duffy-negative individuals contains a point mutation in the GATA1 protein-binding motif, which was suggested to be responsible for erythroid suppression of FY. We developed two transgenic mouse lines with FY from both Duffy phenotypes. Transgenic mice with FY from Duffy-positive phenotype expressed Duffy protein both in red blood cells (RBCs) and non-erythroid tissues. Transgenic mice with FY from Duffy-negative phenotype did not express Duffy protein in RBCs, but it was expressed in non-erythroid tissues. This is the first in vivo experimental evidence showing the effect of -33T-->C promoter mutation on FY expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491299     DOI: 10.1111/j.1365-2141.2004.05208.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.

Authors:  Nicole H Smith; Kate L Henry; Chantel M Cadwell; Ashley Bennett; Jeanne E Hendrickson; Tom Frame; James C Zimring
Journal:  Transfusion       Date:  2012-04-12       Impact factor: 3.157

2.  Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.

Authors:  Weili Bao; Jin Yu; Susanne Heck; Karina Yazdanbakhsh
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.